Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 09-2009 | 12-2008 | 09-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,901 | -5,182 | N/A | -6,770 | -6,770 |
| Depreciation Amortization | 45 | 45 | 40 | 38 | 30 |
| Accounts receivable | N/A | N/A | N/A | 1 | N/A |
| Other Working Capital | 8 | -24 | 70 | 1,544 | 1,540 |
| Other Operating Activity | 801 | 3,605 | 3,500 | 2,852 | 2,870 |
| Operating Cash Flow | $-1,047 | $-1,556 | $3,610 | $-2,336 | $-2,330 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -11 | -59 | N/A | -216 | N/A |
| Other Investing Activity | -11 | -59 | -50 | -216 | -210 |
| Investing Cash Flow | $-11 | $-59 | $-50 | $-216 | $-210 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 75 | N/A | 1,300 | N/A |
| Debt Issued | 571 | -373 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -592 | N/A |
| Common Stock Issued | N/A | 25 | N/A | N/A | N/A |
| Other Financing Activity | 491 | 914 | 560 | 2,010 | 2,710 |
| Financing Cash Flow | $1,061 | $641 | $560 | $2,718 | $2,710 |
| Beginning Cash Position | N/A | 974 | N/A | 808 | 800 |
| End Cash Position | 3 | N/A | N/A | 974 | 970 |
| Net Cash Flow | $3 | $-974 | $4,120 | $166 | $160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,047 | -1,556 | 3,610 | -2,336 | -2,330 |
| Free Cash Flow | -1,047 | -1,556 | 3,610 | -2,336 | -2,330 |